These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Norepinephrine and (Na+, K+)-ATPase: evidence for stabilization by lithium or imipramine.
    Author: Swann AC.
    Journal: Neuropharmacology; 1988 Mar; 27(3):261-7. PubMed ID: 2836750.
    Abstract:
    These experiments examined the effects of lithium and imipramine on the regulation by norepinephrine in vivo of (Na+, K+)-ATPase in brain and heart. The binding of ouabain and the activity of K+-phosphatase were used as indices of (Na+, K+)-ATPase. In the cerebral cortex, imipramine prevented, and lithium reduced, the increase in (Na+, K+)-ATPase associated with repeated injections of yohimbine. Imipramine and yohimbine had synergistic effects on the increased release of norepinephrine and on decreased binding to beta-receptors. Effects on the binding of beta-noradrenergic receptors suggested that imipramine partially reduced stimulation of ATPase by reducing the maximum effect of beta-receptors, while the effect of lithium may have involved a reduction in the exposure of receptors to norepinephrine. Imipramine also increased (Na+, K+)-ATPase in the cerebral cortex of reserpine-treated rats. These results suggest that lithium and imipramine, by different mechanisms, can stabilize fluctuations in the physiological consequences of binding to noradrenergic receptors.
    [Abstract] [Full Text] [Related] [New Search]